{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:46:09Z","timestamp":1766180769305},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00417-015-3031-1","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T03:41:01Z","timestamp":1430710861000},"page":"223-233","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study"],"prefix":"10.1007","volume":"254","author":[{"given":"Irini","family":"Chatziralli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Theodossiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Parikakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Datseris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Theodossiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"key":"3031_CR1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bjo.2009.157313","volume":"93","author":"J Sebag","year":"2009","unstructured":"Sebag J (2009) Vitreous: the resplendent enigma. Br J Ophthalmol 93:989\u2013991","journal-title":"Br J Ophthalmol"},{"key":"3031_CR2","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archopht.119.10.1475","volume":"119","author":"E Uchino","year":"2001","unstructured":"Uchino E, Uemura A, Ohba N (2001) Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol 119:1475\u20131479","journal-title":"Arch Ophthalmol"},{"key":"3031_CR3","first-page":"537","volume":"103","author":"MW Johnson","year":"2005","unstructured":"Johnson MW (2005) Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc 103:537\u2013567","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3031_CR4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1586\/eop.12.34","volume":"7","author":"A Girach","year":"2012","unstructured":"Girach A, Pakola S (2012) Vitreomacular interface diseases. Pathophysiology, diagnosis and future treatment options. Expert Rev Ophthalmol 7:311\u2013323","journal-title":"Expert Rev Ophthalmol"},{"key":"3031_CR5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/IAE.0b013e31829232fd","volume":"33","author":"TL Jackson","year":"2013","unstructured":"Jackson TL, Nicod E, Simpson A, Angelis A, Grimaccia F, Kanavos P (2013) Symptomatic vitreomacular adhesion. Retina 33:1503\u20131511","journal-title":"Retina"},{"key":"3031_CR6","doi-asserted-by":"crossref","unstructured":"Theodossiadis GP, Chatziralli IP, Sergentanis TN, Datseris I, Theodossiadis PG (2014) Evolution of vitreomacular adhesion to acute vitreofoveal separation with special emphasis on a traction-induced foveal pathology. A prospective study of spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (in press). doi: 10.1007\/s00417-014-2826-9","DOI":"10.1007\/s00417-014-2826-9"},{"key":"3031_CR7","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611\u20132619","journal-title":"Ophthalmology"},{"key":"3031_CR8","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/IAE.0b013e3182993ef8","volume":"33","author":"P Stalmans","year":"2013","unstructured":"Stalmans P, Duker JS, Kaiser PK, Heier JS, Dugel PU, Gandorfer A, Sebag J, Haller JA (2013) Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina 33:2003\u20132011","journal-title":"Retina"},{"key":"3031_CR9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IAE.0b013e3181eef08c","volume":"31","author":"D Odrobina","year":"2011","unstructured":"Odrobina D, Michalewska Z, Michalewski J, Dzi\u0119gielewski K, Nawrocki J (2011) Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography. Retina 31:324\u2013331","journal-title":"Retina"},{"key":"3031_CR10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ajo.2014.01.011","volume":"157","author":"GP Theodossiadis","year":"2014","unstructured":"Theodossiadis GP, Grigoropoulos VG, Theodoropoulou S, Datseris I, Theodossiadis PG (2014) Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography. Am J Ophthalmol 157:842\u2013851","journal-title":"Am J Ophthalmol"},{"key":"3031_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archopht.122.2.224","volume":"122","author":"E Ezra","year":"2004","unstructured":"Ezra E, Gregor ZJ, Moorfields Macular Hole Study Group (2004) Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Moorfields Macular Hole Study Group report number 1. Arch Ophthalmol 122:224\u2013236","journal-title":"Arch Ophthalmol"},{"key":"3031_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0002-9394(14)71343-1","volume":"116","author":"T Hikichi","year":"1993","unstructured":"Hikichi T, Akiba J, Trempe CL (1993) Effect of the vitreous on the prognosis of full-thickness idiopathic macular hole. Am J Ophthalmol 116:273\u2013278","journal-title":"Am J Ophthalmol"},{"key":"3031_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9394(00)00358-5","volume":"129","author":"V Mester","year":"2000","unstructured":"Mester V, Kuhn F (2000) Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol 129:769\u2013777","journal-title":"Am J Ophthalmol"},{"key":"3031_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/IAE.0b013e31825bc593","volume":"32","author":"BD Kuppermann","year":"2012","unstructured":"Kuppermann BD (2012) Ocriplasmin for pharmacologic vitreolysis. Retina 32:225\u2013228","journal-title":"Retina"},{"key":"3031_CR15","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s40265-013-0124-1","volume":"73","author":"YY Syed","year":"2013","unstructured":"Syed YY, Dhillon S (2013) Ocriplasmin: a review of its use in patients with symptomatic vitreomacular adhesion. Drugs 73:1617\u20131625","journal-title":"Drugs"},{"key":"3031_CR16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","volume":"367","author":"P Stalmans","year":"2012","unstructured":"Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA, MIVI-TRUST Study Group (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367:606\u2013615","journal-title":"N Engl J Med"},{"key":"3031_CR17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","volume":"122","author":"JA Haller","year":"2015","unstructured":"Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A, Kampik A, Jaffe GJ, Toth CA, MIVI-TRUST Study Group (2015) Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology 122:117\u2013122","journal-title":"Ophthalmology"},{"key":"3031_CR18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00417-014-2645-z","volume":"252","author":"M Codenotti","year":"2014","unstructured":"Codenotti M, Iuliano L, Fogliato G, Querques G, Bandello F (2014) A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome. Graefes Arch Clin Exp Ophthalmol 252:1729\u20131735","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3031_CR19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2014.09.015","volume":"159","author":"DJ Warrow","year":"2015","unstructured":"Warrow DJ, Lai MM, Patel A, Raevis J, Berinstein DM (2015) Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin. Am J Ophthalmol 159:20\u201330","journal-title":"Am J Ophthalmol"},{"key":"3031_CR20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0034-1368372","volume":"231","author":"AP Lommatzsch","year":"2014","unstructured":"Lommatzsch AP, Gutfleisch M, Dietzel M, Heimes B, Spital G, B\u00f6hme M, Bornfeld N, Pauleikhoff D (2014) Initial clinical experience in the treatment of vitreomacular traction and macular holes with ocriplasmin. Klin Monatsbl Augenheilkd 231:909\u2013914","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3031_CR21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/23258160-20130715-05","volume":"44","author":"BT Kim","year":"2013","unstructured":"Kim BT, Schwartz SG, Smiddy WE, Doshi RR, Kovach JL, Berrocal AM, Moshfeghi AA, Fortun JA (2013) Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surg Lasers Imaging Retina 44:334\u2013343","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"3031_CR22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2013-304219","volume":"98","author":"RP Singh","year":"2014","unstructured":"Singh RP, Li A, Bedi R, Srivastava S, Sears JE, Ehlers JP, Schachat AP, Kaiser PK (2014) Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol 98:356\u2013360","journal-title":"Br J Ophthalmol"},{"key":"3031_CR23","doi-asserted-by":"crossref","unstructured":"Sharma P, Juhn A, Houston SK, Fineman M, Chiang A, Ho A, Regillo C (2015) Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Am J Ophthalmol (in press). doi: 10.1016\/j.ajo.2015.01.034","DOI":"10.1016\/j.ajo.2015.01.034"},{"key":"3031_CR24","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1167\/iovs.12-10148","volume":"53","author":"MD Smet de","year":"2012","unstructured":"de Smet MD, Jonckx B, Vanhove M, van Calster J, Stalmans P, Stassen JM (2012) Pharmacokinetics of ocriplasmin in vitreous. Invest Ophthalmol Vis Sci 53:8208\u20138213","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3031_CR25","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1167\/iovs.13-11811","volume":"54","author":"P Stalmans","year":"2013","unstructured":"Stalmans P, Girach A (2013) Vitreous levels of active ocriplasmin following intravitreal injection: results of an ascending exposure trial. Invest Ophthalmol Vis Sci 54:6620\u20136627","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3031_CR26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00417-004-0934-7","volume":"242","author":"CH Meyer","year":"2004","unstructured":"Meyer CH, Rodrigues EB, Mennel S, Schmidt JC, Kroll P (2004) Spontaneous separation of epiretinal membrane in young subjects: personal observations and review of the literature. Graefes Arch Clin Exp Ophthalmol 242:977\u2013985","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3031_CR27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/ICB.0000000000000061","volume":"8","author":"A Thanos","year":"2014","unstructured":"Thanos A, Hernandez-Siman J, Marra KV, Arroyo JG (2014) Reversible vision loss and outer retinal abnormalities after intravitreal ocriplasmin injection. Retin Cases Brief Rep 8:330\u2013332","journal-title":"Retin Cases Brief Rep"},{"key":"3031_CR28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/eye.2013.94","volume":"27","author":"KB Freund","year":"2013","unstructured":"Freund KB, Shah SA, Shah VP (2013) Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin. Eye 27:773\u2013774","journal-title":"Eye"},{"key":"3031_CR29","doi-asserted-by":"crossref","unstructured":"Hager A, Seibel I, Riechardt A, Rehak M, Joussen AM (2014) Does ocriplasmin affect the RPE-photoreceptor adhesion in macular holes? Br J Ophthalmol (in press). doi: 10.1136\/bjophthalmol-2014-305620","DOI":"10.1136\/bjophthalmol-2014-305620"},{"key":"3031_CR30","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.ophtha.2014.07.044","volume":"121","author":"Y Itoh","year":"2014","unstructured":"Itoh Y, Kaiser PK, Singh RP, Srivastava SK, Ehlers JP (2014) Assessment of retinal alterations after intravitreal ocriplasmin with spectral-domain optical coherence tomography. Ophthalmology 121:2506\u20132507","journal-title":"Ophthalmology"},{"key":"3031_CR31","doi-asserted-by":"crossref","unstructured":"Chod RB, Goodrich C, Saxena S, Akduman L (2015) Lamellar macular hole after intravitreal ocriplasmin injection. BMJ Case Rep (in press). doi: 10.1136\/bcr-2014-207810","DOI":"10.1136\/bcr-2014-207810"},{"key":"3031_CR32","first-page":"403461","volume":"2014","author":"E Casswell","year":"2014","unstructured":"Casswell E, Fernandez-Sanz G, Mitry D, Luk S, Zakir R (2014) Macular hole progression following ocriplasmin intravitreal injection. Case Rep Ophthalmol Med 2014:403461","journal-title":"Case Rep Ophthalmol Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3031-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-015-3031-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3031-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:52Z","timestamp":1559072452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-015-3031-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1007\/s00417-015-3031-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,5]]}}}